Angiodynamics (ANGO) Change in Inventory (2010 - 2026)

Angiodynamics has reported Change in Inventory for 17 years, with the latest figure at -$7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 151.14% year-over-year to -$7.1 million; the trailing twelve-month figure through Feb 2026 stood at -$4.7 million (down 193.15% YoY), and the FY2025 full-year result was $1.3 million, down 85.69% from the prior year.
• Change in Inventory for Q1 2026 stood at -$7.1 million, down from $3.3 million in the prior quarter.
• The five-year high for Change in Inventory was $6.2 million in Q3 2022, with the low at -$7.1 million in Q1 2026.
• Historically, Change in Inventory has averaged $1.1 million across 5 years, with a median of $1.2 million in 2024.
• Annual changes were most pronounced in 2022 — Change in Inventory jumped 905.71% — and 2024, when it tumbled 577.3%.
• Angiodynamics' Change in Inventory stood at $5.6 million in 2022, then retreated by 23.65% to $4.3 million in 2023, then sank by 70.73% to $1.2 million in 2024, then jumped by 162.48% to $3.3 million in 2025, then tumbled by 315.09% to -$7.1 million in 2026.
• The last three Change in Inventory figures came in at -$7.1 million (Q1 2026), $3.3 million (Q4 2025), and $192000.0 (Q3 2025), per Business Quant data.